Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

A woman had a rare reaction to ear piercing that caused earlobe swelling, which was best treated by removing the piercing and not re-piercing.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Researchers found a good way to isolate hair follicle stem cells from newborn goats for further study.

A specific group of stem cells can help regenerate hair continuously.

Blocking certain proteins on immune cells may help treat alopecia areata.

The Foxn1(-/-) phenotype disrupts hair growth and affects skin stem cells.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Developing human skin has immune cells with memory-like features.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

IL-18 signaling helps mature Tregs move into the thymus.

IL-18 signaling helps mature Tregs move into the thymus.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.